Use of galactomannan enzyme immunoassay for diagnosis of invasive aspergillosis in a tertiary-care center over a 12-month period [6]

Journal of Clinical Microbiology

Volumn 44, Issue 4, 2006, Pages 1601-

  Zedek, Daniel C ^a   Miller, Melissa B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; GALACTOMANNAN;

ASPERGILLOSIS; BONE MARROW TRANSPLANTATION; COMPUTER ASSISTED TOMOGRAPHY; ENZYME IMMUNOASSAY; HEART TRANSPLANTATION; HUMAN; LETTER; LUNG ASPERGILLOSIS; LUNG BIOPSY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN BIOPSY; STEM CELL TRANSPLANTATION; TERTIARY HEALTH CARE;

ACADEMIC MEDICAL CENTERS; ASPERGILLOSIS; ASPERGILLUS; HEMATOLOGIC NEOPLASMS; IMMUNOENZYME TECHNIQUES; MANNANS; OPPORTUNISTIC INFECTIONS;

EID: 33645926352     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.4.1601.2006     Document Type: Letter

References (9)

1. Herbrecht, R., V. Letscher-Bru, C. Oprea, et al. 2002. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J. Clin. Oncol. 20:1898-1906.
2. Machetti, M., M. Feasi, N. Mordini, et al. 1998. Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients. Bone Marrow Transplant. 21:917-921.
3. Maertens, J., J. Van Eldere, J. Verhaegen, E. Verbeken, J. Verschakelen, and M. Boogaerts. 2002. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J. Infect. Dis. 186:1297-1306.
4. Maertens, J., J. Verhaegen, H. Demuynck, et al. 1999. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J. Clin. Microbiol. 37:3223-3228.
5. Maertens, J., J. Verhaegen, K. Lagrou, J. Van Eldere, and M. Boogaerts. 2001. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 97:1604-1610.
6. Marr, K. A., R. A. Carter, F. Crippa, A. Wald, and L. Corey. 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34:909-917.
7. Pinel, C., H. Fricker-Hidalgo, B. Lebeau, et al. 2003. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J. Clin. Microbiol. 41:2184-2186.
8. Siemann, M., M. Koch-Dorfler, and M. Gaude. 1998. False-positive results in premature infants with the Platelia Aspergillus sandwich enzyme-linked immunosorbent assay. Mycoses 41:373-377.
9. Williamson, E. C., D. A. Oliver, E. M. Johnson, A. B. Foot, D. I. Marks, and D. W. Warnock. 2000. Aspergillus antigen testing in bone marrow transplant recipients. J. Clin. Pathol. 53:362-366.